Bianca Mazzitelli
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.
Journal: Nature communications
Published: February 17, 2023
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina.
Journal: Frontiers in immunology
Published: July 12, 2022
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people.
Journal: The Lancet. Infectious diseases
Published: May 16, 2022
Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response.
Journal: The Journal of infectious diseases
Published: May 03, 2022
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.
Journal: EBioMedicine
Published: April 13, 2022
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Journal: Cell reports. Medicine
Published: March 30, 2022
Antibody durability at 1 year after Sputnik V vaccination.
Journal: The Lancet. Infectious diseases
Published: February 25, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026